Médecins Sans Frontières (MSF) translates to Doctors without Borders. We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.
Following the recent approval by the US Food and Drug Administration (FDA) of the Thoraflex Hybrid frozen elephant trunk (FET) device for the treatment of patients with complex aortic arch disease, Terumo Aortic has now announced the first commercial implant of the device in the USA.
Tho
Posted by admin on Aug 10th, 2022
Shares of NuVasive, Inc. (NASDAQ:NUVA – Get Rating) have earned a consensus rating of “Hold” from the fifteen research firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock
Posted by admin on Aug 8th, 2022
NuVasive (NASDAQ:NUVA – Get Rating) had its price target trimmed by Piper Sandler from $80.00 to $60.00 in a report released on Thursday, Marketbeat reports. The brokerage currently has an overweight rating on the medical device compa
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
NuVasive (NASDAQ:NUVA - Get Rating) issued an update on its FY 2022 earnings guidance on Wednesday morning. The company provided EPS guidance of $2.15-$2.45 for the period, compared to the cons
Posted by admin on Aug 12th, 2022
Victory Capital Management Inc. reduced its position in shares of NuVasive, Inc. (NASDAQ:NUVA – Get Rating) by 19.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Shares of NuVasive, Inc. (NASDAQ:NUVA - Get Rating) have earned a consensus rating of "Hold" from the fifteen research firms that are covering the firm, Marketbeat.com reports. One investment a
Wide-ranging market information of the Global Spinal Stenosis Implant Market report will surely grow business and improve return on investment (ROI). The report has been prepared by taking into account several aspects of marketing research and analysis which includes Spinal Stenosis Implant
Privacy Policy | Advertising Policy | Privacy Preferences Center | Do Not Sell My Personal Information
© Copyright 2022 Healthgrades Marketplace, LLC, a Red Ventures Company, Patent US Nos. 7,752,060 and 8,719,052. All Rights Reserved. Third Party materials